PTC Therapeutics
PTCT
PTCT
184 hedge funds and large institutions have $2.09B invested in PTC Therapeutics in 2019 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 69 increasing their positions, 55 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
184
Holders Change
+8
Holders Change %
+4.55%
% of All Funds
4.04%
Holding in Top 10
7
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-22.22%
% of All Funds
0.15%
New
34
Increased
69
Reduced
55
Closed
26
Calls
$39.3M
Puts
$28.4M
Net Calls
+$10.9M
Net Calls Change
+$5.92M
Top Buyers
| 1 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$55.9M |
| 2 |
Franklin Resources
San Mateo,
California
|
+$42M |
| 3 |
RI
RTW Investments
New York
|
+$17.4M |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$15.7M |
| 5 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$13.1M |
Top Sellers
| 1 |
Millennium Management
New York
|
-$35M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$8.92M |
| 3 |
State Street
Boston,
Massachusetts
|
-$8.08M |
| 4 |
Renaissance Technologies
New York
|
-$8.08M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$6.18M |
